Publication | Closed Access

A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction

Molecular PharmacologyErectile DysfunctionMedicineSexual DysfunctionNeuropharmacologyPharmacotherapyNon-psychogenic Erectile DysfunctionNovel Auto-injectorPharmacologyDouble BlindAnesthesiology